Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S., India at odds over trade as Trump heads for encounter with Modi: U.S. officials

Published 02/21/2020, 04:45 PM
Updated 02/21/2020, 04:45 PM
© Reuters. FILE PHOTO: Man holds the flags while people take part in the 35th India Day Parade in New York

By David Lawder

WASHINGTON (Reuters) - Trump administration officials on Friday acknowledged that U.S. President Donald Trump's visit to India next week will not result in even a limited trade deal, saying they still have major concerns over India's trade barriers.

Hopes that the world's two largest democracies could negotiate a "confidence building" deal in time for Trump's arrival Monday on a two-day visit have faded in recent days as differences over agriculture, medical devices, digital trade and proposed new tariffs fester, according to business groups.

U.S. concerns that led last year to the suspension of India's tariff free access for some $5.6 billion in exports under the 1970s-era Generalized System of Preferences still remain, a senior Trump administration official told reporters on a conference call.

"We do want to make sure that we get this balance right. We want to address a lot of concerns and we're not quite there yet," the official said, adding that Trump will likely discuss these concerns with Indian Prime Minister Narendra Modi.

Trade talks will continue, but new Indian tariff proposals aimed at strengthening the country's "Make in India" domestic manufacturing push have made them more difficult, the official said.

Apart from growing protectionism, the Trump visit comes against the backdrop of India's multibillion-dollar purchase of a Russian missile shield system, which added friction to its ties with Washington.

India in its Feb. 1 budget proposal announced new import tariffs on medical devices, walnuts, toys, electronics and other products in a move aimed at reducing imports from China but affecting many U.S. firms.

The new tariffs surprised U.S. negotiators, especially as they were working with Indian counterparts to reduce the impact of India's price controls on U.S. medical devices such as cardiac stents and knee implants.

"We will be discussing those concerns and what we see an increase in barriers not a decrease. This will certainly come up among the leaders," the U.S. official said.

The official did not completely rule out any trade related announcements during the trip, but said this was "really wholly dependent on what the Indians are prepared to do."

U.S. Trade Representative Robert Lighthizer, who has been leading the trade discussions, will not be among the U.S. delegation accompanying Trump, the official said. Earlier this month, Lighthizer canceled a trip to India to work out a package, even as India made some new proposals to improve U.S. dairy and poultry access. [L1N2AD27O]

U.S. Commerce Secretary Wilbur Ross is joining the trip, which will include announcements of commercial transactions in the energy and defense sectors, the officials said.

© Reuters. FILE PHOTO: Man holds the flags while people take part in the 35th India Day Parade in New York

The United States is India's second-largest trade partner after China, and bilateral goods and services trade climbed to a record $142.6 billion in 2018. The United States had a $23.2 billion goods trade deficit in 2019 with India, its 9th largest trading partner in goods.

Latest comments

A LOT of Indian equipment and goods being made there and sent here, especially to pharma. companies which also, and enough people to run thye entire company. They are HEAVILY populated with those from India in an almost "reverse discrim." look tho it. Don't get me wrong, I'd prefer to have manufacturing occur in a non-communist country but IF they tariff or goods as much as I've heard, alas fair ! Hand it back and perhaps the globalists will take back some manufacturing. We shall see -
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.